Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences
Shuling Chen(Jiangsu University of Science and Technology), Ming Kuang(Sun Yat-sen University), Wenxuan Xie(Sun Yat-sen University), Hui‐Chuan Sun(Fudan University), Huanjing Hu(Sun Yat-sen University), Minghui He(Unknown), Zihao Dai(Sun Yat-sen University), Dan G. Duda(Harvard University), Dong‐Ming Kuang(Sun Yat-sen University), Sui Peng(Sun Yat-sen University), Yubin Xie(Sun Yat-sen University), Shunli Shen(Sun Yat-sen University), Xuezhen Zeng(Sun Yat-sen University), Qiang Zhao(First Affiliated Hospital of Zhengzhou University), Changyi Liao(Sun Yat-sen University), Guanrui Liao(Beth Israel Deaconess Medical Center), Shaoqiang Li(State Key Laboratory of Respiratory Disease), Xiaoxue Ren(Sun Yat-sen University), Jianping Wang(Sun Yat-sen University), Cheng Huang(Fujian Medical University), Guopei Zhang(The First Affiliated Hospital, Sun Yat-sen University), Zhilong Lin(Sun Yat-sen University)
Cited by 66
Related Papers
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
IBS: an illustrator for the presentation and visualization of biological sequences
|Bioinformatics|2015|1.1k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
|Angiogenesis|2017|690
GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs
|Nucleic Acids Research|2014|541